SCHEMBL28449191

SCHEMBL28449191

CCOC(=O)CCc1nc2cc(Br)ccc2nc1Oc1ccc(C(=O)OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.43
KDM4E B2RXH2 3/20 0.42
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 4/20 0.39
ATM Q13315 1/20 0.39
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 5/20 0.38
LMNA P02545 3/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 1/20 0.37
USP10 Q14694 1/20 0.37
TSHR P16473 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28443100 0.87 KDM4E (0.44) EGFRKDM4ESMN1; SMN2MAPTKMT2A
SCHEMBL28451603 0.85 ALDH1A1 (0.43) EGFRKDM4ESMN1; SMN2MAPTL3MBTL1
SCHEMBL28445463 0.85 ALDH1A1 (0.43) EGFRKDM4ESMN1; SMN2MAPTL3MBTL1
SCHEMBL28452127 0.84 KMT2A (0.40) EGFRKDM4ESMN1; SMN2MAPTKMT2A
SCHEMBL28443055 0.76 KDM4E (0.54) KDM4ESMN1; SMN2MAPTKMT2AL3MBTL1
SCHEMBL28447306 0.76 EGFR (0.46) EGFRKDM4ESMN1; SMN2MAPTATM
SCHEMBL28445478 0.76 EGFR (0.46) EGFRKDM4ESMN1; SMN2MAPTATM
SCHEMBL28445422 0.75 KDM4E (0.44) EGFRKDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL28454187 0.75 KDM4E (0.44) EGFRKDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL28449263 0.74 KDM4E (0.52) KDM4EMAPTL3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108997230-B Quinoxaline derivative with matrix metalloproteinase inhibitory activity, preparation method and application thereof 山东大学 2020-08-04 CN claimed
CN-108997230-B Quinoxaline derivative with matrix metalloproteinase inhibitory activity, preparation method and application thereof 山东大学 2020-08-04 CN disclosed